By Chloe Elmer
Clinicians face an unusual challenge when it comes to diagnosing patients with mild cognitive impairment, commonly called MCI, and what that may or may not mean for their future.
Not all MCI patients develop dementia — some may show no decline over a 10-year period — but the diagnosis can still be helpful. It fosters discussions between physician and patient/family about important issues such as long-term financial planning and expectations.
Meanwhile, recently-approved PET scans can help determine an “elevated risk” of developing Alzheimer’s disease dementia through the identification of amyloid, but clinicians must proceed with caution when discussing these scan results.
These were a few of the comments from researchers in a new guide for clinicians on effective communication with patients and families regarding the diagnosis and possible outcomes of MCI. The 12 recommendations were recently published in the journal “Alzheimer’s Research & Therapy Journal.”